Mr. Shah has more than a decade of experience developing and commercializing innovative medical technology. Mr. Shah will oversee SetPoint's efforts to commercialize its proprietary bioelectronic device as the company advances their bioelectronic medicine approach to treat autoimmune inflammatory diseases including rheumatoid arthritis, Crohn's disease and multiple sclerosis.


More...